## **Core Concept**
The question tests the understanding of opportunistic infections in immunocompromised patients, specifically those who have undergone organ transplantation. Immunosuppressed individuals are susceptible to a variety of pathogens, including bacteria, viruses, and fungi, due to their compromised immune system. The clinical presentation of bilateral diffuse interstitial pneumonia in a transplant patient suggests an infectious etiology.

## **Why the Correct Answer is Right**
The correct answer, **C. Cytomegalovirus (CMV)**, is a common cause of pneumonia in immunocompromised patients, especially those who have received organ transplants. CMV pneumonia typically presents with bilateral interstitial infiltrates on chest radiography and can cause significant morbidity in transplant recipients. CMV is a DNA virus that can reactivate from a latent state or be acquired from the donor organ. The risk of CMV infection is highest in the first few months after transplantation, making it a prime suspect in this patient presenting 2 months post-transplant.

## **Why Each Wrong Option is Incorrect**
- **Option A:** While *Pneumocystis jirovecii* (formerly *P. carinii*) can cause pneumonia in immunocompromised patients, it typically presents with bilateral ground-glass opacifications and is more commonly associated with HIV/AIDS or patients on specific immunosuppressive regimens like corticosteroids. However, it's less directly linked to the timeframe and transplant status as specifically as CMV.
- **Option B:** *Mycoplasma pneumoniae* typically causes mild community-acquired pneumonia and is less likely to present as bilateral diffuse interstitial pneumonia in an immunocompromised patient, especially in the context of recent organ transplantation.
- **Option D:** *Aspergillus* species can cause pneumonia in immunocompromised patients, often presenting with focal lesions or nodular infiltrates rather than bilateral diffuse interstitial pneumonia. While possible, it's less commonly associated with this specific presentation compared to CMV.

## **Clinical Pearl / High-Yield Fact**
A key point to remember is that CMV pneumonia is a significant risk in transplant patients, particularly in the first few months post-transplant. Screening for CMV IgG status is routine in transplant protocols, and prophylactic measures, including antiviral medications, are often employed to prevent CMV disease in seronegative recipients of seropositive organs.

## **Correct Answer:** C. Cytomegalovirus (CMV).